Pharmaceutical Care (Allemann)

Bollinger, Anna et al. (2025) ‘Analgesic therapy failure in a COMT HPS/HPS diplotype carrier heterozygous for the CYP2D6 *4 allele with fibromyalgia—a case report’, PAIN Reports, 10(2). Available at: https://doi.org/10.1097/PR9.0000000000001248.

Wittwer, Nina L. et al. (2025) ‘Pharmacogenetic Testing in the Outpatient Setting in Switzerland: A Descriptive Study Using Swiss Claims Data’, Drug Safety [Preprint]. Available at: https://doi.org/10.1007/s40264-025-01522-z.

Bollinger, A. et al. (2025) ‘Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective’, Pharmacy, 13(1), p. 14. Available at: https://doi.org/10.3390/pharmacy13010014.

Bollinger, Anna et al. (2025) ‘Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective’, Pharmacy, 13(1), p. 14. Available at: https://doi.org/10.3390/pharmacy13010014.

Wiss, Florine M. et al. (2024) ‘Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol’, BMC Medical Genomics, 17(1). Available at: https://doi.org/10.1186/s12920-024-02064-6.

Wiss, Florine M. et al. (2024) ‘Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol’, BMC Medical Genomics, 17(1). Available at: https://doi.org/10.1186/s12920-024-02064-6.

Barbati, Selina et al. (2024) ‘Concordance between pharmacy dispensing and electronic monitoring data of direct oral anticoagulants - A secondary analysis of the MAAESTRO study’, Research in Social and Administrative Pharmacy, 20(12), pp. 1096–1101. Available at: https://doi.org/10.1016/j.sapharm.2024.08.090.

Barbati, Selina et al. (2024) ‘Concordance between pharmacy dispensing and electronic monitoring data of direct oral anticoagulants - A secondary analysis of the MAAESTRO study’, Research in Social and Administrative Pharmacy, 20(12), pp. 1096–1101. Available at: https://doi.org/10.1016/j.sapharm.2024.08.090.

Bollinger, Anna et al. (2024) ‘Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report’, BMC Anesthesiology, 24(1). Available at: https://doi.org/10.1186/s12871-024-02797-y.

Wiss, Florine M. et al. (2024) ‘Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol’, BMC Medical Genomics, 17(1). Available at: https://doi.org/10.1186/s12920-024-02064-6.

Bollinger, Anna et al. (2024) ‘Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report’, BMC Anesthesiology, 24(1). Available at: https://doi.org/10.1186/s12871-024-02797-y.

Hoarau, Damien et al. (2024) ‘Determinants of adherence to post-stroke/transient ischemic attack secondary prevention medications: A cohort study’, European Journal of Neurology, 31(10). Available at: https://doi.org/10.1111/ene.16395.

Pal, Avishek et al. (2024) ‘Practices and barriers in developing and disseminating plain-language resources reporting medical research information: A scoping review’, Patient - Patient-Centered Outcomes Research, 17(5), pp. 493–518. Available at: https://doi.org/10.1007/s40271-024-00700-y.

Amiesimaka, Obreniokibo Ibifubara et al. (2024) ‘Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis’, British Journal of Clinical Pharmacology, 90(8), pp. 1911–1920. Available at: https://doi.org/10.1111/bcp.16069.

Arnet, Isabelle et al. (2024) ‘Inconclusiveness of psychometric testing of medication adherence questionnaires’, European Journal of Clinical Pharmacology, 80(8), pp. 1189–1195. Available at: https://doi.org/10.1007/s00228-024-03684-8.

Arnet, Isabelle et al. (2024) ‘Inconclusiveness of psychometric testing of medication adherence questionnaires’, European Journal of Clinical Pharmacology, 80(8), pp. 1189–1195. Available at: https://doi.org/10.1007/s00228-024-03684-8.

Wiss, Florine M. et al. (2024) ‘Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice’, Genes, 15(7). Available at: https://doi.org/10.3390/genes15070862.

Isabelle, Arnet et al. (2024) ‘The 8‐item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients’, Journal of Evaluation in Clinical Practice, 30(4), pp. 582–583. Available at: https://doi.org/10.1111/jep.13975.

Rekk, Katharina et al. (2024) ‘Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke—A case control study’, PLOS ONE, 19(4), p. e0301421. Available at: https://doi.org/10.1371/journal.pone.0301421.

Rekk, Katharina et al. (2024) ‘Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study’, PLoS ONE, 19(4 April). Available at: https://doi.org/10.1371/journal.pone.0301421.

Stäuble, Céline K. et al. (2024) ‘A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions’, Clinical Pharmacology & Therapeutics [Preprint]. Available at: https://doi.org/10.1002/cpt.3247.

Arnet, Isabelle et al. (2024) ‘Development and validation of the 15-STARS - A novel self-report pharmacy-based questionnaire to screen for medication non-adherence’, Research in Social and Administrative Pharmacy, 20(3), pp. 308–320. Available at: https://doi.org/10.1016/j.sapharm.2023.11.005.

Alexa, Jennifer (2024) Pharmacy Consultation Guide. 2 edn. 2. W. Kohlhammer GmbH, p. 135. Available at: https://doi.org/10.17433/978-3-17-041139-5.

Barbati, Selina et al. (2024) ‘Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study’, Health Science Reports, 7(1). Available at: https://doi.org/10.1002/hsr2.1814.

Barbati, Selina et al. (2024) ‘Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study’, Health Science Reports, 7(1). Available at: https://doi.org/10.1002/hsr2.1814.

Dietrich, Fine et al. (2024) ‘Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners’, BMJ Open Quality, 13(1), p. e002451. Available at: https://doi.org/10.1136/bmjoq-2023-002451.

Messner, Kirstin et al. (2023) ‘Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic’, BMC Health Services Research, 23(1). Available at: https://doi.org/10.1186/s12913-023-10475-x.

Alexa, J. M. and Bertsche, T. (2023) ‘An online cross-sectional survey of community pharmacists to assess information needs for evidence-based self-medication counselling’, International Journal of Clinical Pharmacy, 45(6), pp. 1452–1463. Available at: https://doi.org/10.1007/s11096-023-01624-7.

Jeiziner, Chiara et al. (2023) ‘Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service’, International Journal of Clinical Pharmacy, 45(6), pp. 1378–1386. Available at: https://doi.org/10.1007/s11096-023-01596-8.

Messner, Kirstin et al. (2023) ‘Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic’, BMC Health Services Research, 23(1). Available at: https://doi.org/10.1186/s12913-023-10475-x.

Dietrich, Fine et al. (2023) ‘Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)’, Journal of Neurology [Preprint]. Available at: https://doi.org/10.1007/s00415-023-12035-z.

Bollinger, Anna et al. (2023) ‘Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report’, Pharmacogenomics, 24(14), pp. 739–746. Available at: https://doi.org/10.2217/pgs-2023-0122.

Bollinger, Anna et al. (2023) ‘Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report’, Pharmacogenomics, 24(14), pp. 739–746. Available at: https://doi.org/10.2217/pgs-2023-0122.

Bollinger, A. et al. (2023) ‘Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report’, Pharmacogenomics, 24(14), pp. 739–746. Available at: https://doi.org/10.2217/pgs-2023-0122.

Arnet, Isabelle et al. (2023) ‘Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment’, European Addiction Research, 29(4), pp. 253–263. Available at: https://doi.org/10.1159/000530266.

Dima, Alexandra L et al. (2023) ‘Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework’, British Journal of Clinical Pharmacology, 89(7), pp. 1918–1927. Available at: https://doi.org/10.1111/bcp.15375.

Alexa, Jennifer Maria, Richter, Matthias and Bertsche, Thilo (2023) ‘Enhancing Evidence-Based Pharmacy by Comparing the Quality of Web-Based Information Sources to the EVInews Database: Randomized Controlled Trial With German Community Pharmacists’, Journal of Medical Internet Research, 25, p. e45582. Available at: https://doi.org/10.2196/45582.

Wiss, Florine M et al. (2023) ‘Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy’, Journal of Personalized Medicine, 13(5), p. 829. Available at: https://doi.org/10.3390/jpm13050829.

Bertsche, Thilo et al. (2023) ‘Self-care and self-medication as central components of healthcare in Germany – on the way to evidence-based pharmacy’, Exploratory Research in Clinical and Social Pharmacy, 9, p. 100257. Available at: https://doi.org/10.1016/j.rcsop.2023.100257.

Tan, Michael et al. (2023) ‘Adherence patterns in antiseizure medications influencing risk of sudden unexplained death in epilepsy: A data linkage study using dispensed prescriptions’, Epilepsia, 64(3), pp. 641–653. Available at: https://doi.org/10.1111/epi.17502.

Dietrich, Fine et al. (2023) ‘Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study’, BMJ Open Quality, 12(1), p. e002155. Available at: https://doi.org/10.1136/bmjoq-2022-002155.

Rothen, Jean-Pierre et al. (2023) ‘Renal insufficiency and magnesium deficiency correlate with a decreased formation of biologically active cholecalciferol: a retrospective observational study’, International Journal of Clinical Pharmacy, 45(1), pp. 240–244. Available at: https://doi.org/10.1007/s11096-022-01485-6.

Amador-Fernández, Noelia et al. (2023) ‘Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments’, Frontiers in Pharmacology, 14. Available at: https://doi.org/10.3389/fphar.2023.1256172.

Arnet, I. et al. (2023) ‘Non-adherence and epileptic emergency—reasons and solutions’, Clinical Epileptology, null. Available at: https://doi.org/10.1007/s10309-023-00627-8.

Bollinger, Anna et al. (2023) ‘Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study’, Pharmacogenomics and Personalized Medicine, 16, pp. 693–706. Available at: https://doi.org/10.2147/PGPM.S415259.

do Prado, Luiza Siqueira et al. (2023) ‘Toward an Interdisciplinary Approach to Constructing Care Delivery Pathways From Electronic Health Care Databases to Support Integrated Care in Chronic Conditions: Systematic Review of Quantification and Visualization Methods’, Journal of Medical Internet Research, 25(1). Available at: https://doi.org/10.2196/49996.

Dalli, Lachlan L et al. (2022) ‘Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS’, British Journal of Clinical Pharmacology, 88(10), pp. 4427–4442. Available at: https://doi.org/10.1111/bcp.15391.

Stäuble, Céline K. et al. (2022) ‘A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting’, Pharmacy, 10(4), p. 86. Available at: https://doi.org/10.3390/pharmacy10040086.

Stäuble, Céline K. et al. (2022) ‘A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting’, Pharmacy, 10(4), p. 86. Available at: https://doi.org/10.3390/pharmacy10040086.

Stäuble, Céline K et al. (2022) ‘Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene’, Frontiers in Psychiatry, 13, p. 942268. Available at: https://doi.org/10.3389/fpsyt.2022.942268.

Stäuble, Céline K et al. (2022) ‘Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene’, Frontiers in Psychiatry, 13, p. 13. Available at: https://doi.org/10.3389/fpsyt.2022.942268.

Baumgartner, Pascal C et al. (2022) ‘Development and testing of a framework for defining a strategy to address medication adherence during patient encounters in community pharmacies’, Exploratory Research in Clinical and Social Pharmacy, 5, p. 100123. Available at: https://doi.org/10.1016/j.rcsop.2022.100123.

Bandiera, Carole et al. (2022) ‘Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action’, International Journal of Public Health, 67, p. 1605204. Available at: https://doi.org/10.3389/ijph.2022.1605204.

Baumgartner, Pascal C et al. (2022) ‘Delta T, a Useful Indicator for Pharmacy Dispensing Data to Monitor Medication Adherence’, Pharmaceutics, 14(1), p. 103. Available at: https://doi.org/10.3390/pharmaceutics14010103.

Jeiziner, Chiara et al. (2022) ‘Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report’, Pharmacogenomics and Personalized Medicine, 15, pp. 465–475. Available at: https://doi.org/10.2147/PGPM.S354011.

Stäuble, Céline K. et al. (2022) ‘A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting’, Pharmacy (Basel, Switzerland), 10(4), p. 86. Available at: https://doi.org/10.3390/pharmacy10040086.

Wittwer, Nina L et al. (2022) ‘Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database’, Pharmacogenomics and Personalized Medicine, 15, pp. 967–976. Available at: https://doi.org/10.2147/PGPM.S382214.

Yous, Tamara et al. (2022) ‘Development of a Protocol Using the Delphi Method for the ad interim Supply of Hormonal Contraceptives in Swiss Pharmacies.’, Pharmacy (Basel, Switzerland), 10(6), p. 10.3390/pharmacy10060168. Available at: https://doi.org/10.3390/pharmacy10060168.

Stäuble, Céline K et al. (2021) ‘Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial’, Trials, 22(1), p. 919. Available at: https://doi.org/10.1186/s13063-021-05724-5.

Stäuble, Céline K et al. (2021) ‘Pharmacogenetic-guided antidepressant selection as an opportunity for interprofessional collaboration: A case report’, Life, 11(7), p. 673. Available at: https://doi.org/10.3390/life11070673.

Dima, Alexandra L et al. (2021) ‘TEOS: A framework for constructing operational definitions of medication adherence based on Timelines–Events–Objectives–Sources’, British Journal of Clinical Pharmacology, 87(6), pp. 2521–2533. Available at: https://doi.org/10.1111/bcp.14659.

Jeiziner, Chiara et al. (2021) ‘Enriching medication review with a pharmacogenetic profile – a case of tamoxifen adverse drug reactions’, Pharmacogenomics and Personalized Medicine, 14, pp. 279–286. Available at: https://doi.org/10.2147/pgpm.s285807.

Stäuble, Céline K et al. (2021) ‘Pharmacogenetics in Pharmaceutical Care-Piloting an Application-Oriented Blended Learning Concept.’, Pharmacy (Basel, Switzerland), 9(3), p. 152. Available at: https://doi.org/10.3390/pharmacy9030152.

Stäuble, Céline K. et al. (2021) ‘Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying; CYP2D6; *4 Variants: A Case Report’, International Journal of Molecular Siences, 22(12), p. 6480. Available at: https://doi.org/10.3390/ijms22126480.

Yous, Tamara, Allemann, Samuel and Lutters, Monika (2021) ‘Physicians” Opinion Regarding Extended Access to Hormonal Contraception in Switzerland.’, Pharmacy (Basel, Switzerland), 9(4), p. 184. Available at: https://doi.org/10.3390/pharmacy9040184.

Stäuble, Céline K et al. (2020) ‘Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: A case report’, Pharmacogenomics, 21(16), pp. 1145–1150. Available at: https://doi.org/10.2217/pgs-2020-0087.

Martinez-De la Torre, Adrian et al. (2020) ‘National Poison Center Calls before vs after Availability of High-Dose Acetaminophen (Paracetamol) Tablets in Switzerland’, JAMA Network Open, 3(10), p. e2022897. Available at: https://doi.org/10.1001/jamanetworkopen.2020.22897.

Siqueira do Prado, Luiza et al. (2020) ‘Quantification and visualisation methods of data-driven chronic care delivery pathways: Protocol for a systematic review and content analysis’, BMJ Open, 10(3), p. e033573. Available at: https://doi.org/10.1136/bmjopen-2019-033573.

Yous, Tamara, Allemann, Samuel and Lutters, Monika (2020) ‘Extended Access to Hormonal Contraception in Pharmacies: A Survey among Swiss Pharmacists.’, Pharmacy (Basel, Switzerland), 8(4), p. 210. Available at: https://doi.org/10.3390/pharmacy8040210.

Alexa, Jennifer (2019) Pharmacy Consultation Guide. 1 edn. 1. Stuttgart: W. Kohlhammer GmbH, p. 114. Available at: https://doi.org/10.17433/978-3-17-035969-7.

Dima, Alexandra, Allemann, Samuel and Dediu, Dan (2019) ‘AdhereR: An Open Science Approach to Estimating Adherence to Medications Using Electronic Healthcare Databases.’, Studies in health technology and informatics, 264, pp. 1451–1452. Available at: https://doi.org/10.3233/shti190479.

Rouzé, Héloïse et al. (2019) ‘Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data.’, Patient preference and adherence, 13, pp. 1497–1510. Available at: https://doi.org/10.2147/ppa.s211769.

Gregoriano, C. et al. (2017) Prescription and use of inhaled medication in patients with asthma and COPD: Baseline-data of an adherence-Intervention-study. JMIR Publications Inc. Available at: https://doi.org/10.2196/preprints.9246.